MAPT and Alzheimer disease: Many studies have indicated that Aβo accumulation triggers the downstream pathology of AD, including hyperphosphorylation of tau (Mucke and Selkoe, 2012), but no mechanism has previously been identified that clearly links these two critical players in AD pathology.